Page last updated: 2024-08-21

isoxazoles and thromboxane a2

isoxazoles has been researched along with thromboxane a2 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demina, OV; Shram, SI; Varfolomeev, SD; Vrzheshch, PV1
Fujita, H; Morita, I; Sato, T; Tanaka, N1
Fitzgerald, GA1
Bernstein, SH; Chiorazzi, N; Felgar, RE; Kaur, K; Phipps, RP; Pollock, SJ; Ryan, EP1
Dogné, JM; Hanson, J; Pratico, D; Supuran, C1
Araujo, M; Welch, WJ1
Bruno, A; Dovizio, M; Lavecchia, A; Malerba, P; Marcantoni, E; Patrignani, P; Perrone, MG; Scilimati, A; Simone, L; Tacconelli, S; Vitale, P1

Reviews

1 review(s) available for isoxazoles and thromboxane a2

ArticleYear
Coxibs and cardiovascular side-effects: from light to shadow.
    Current pharmaceutical design, 2006, Volume: 12, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Epoprostenol; Humans; Isoxazoles; Lactones; Pyrazoles; Structure-Activity Relationship; Sulfonamides; Sulfones; Thromboxane A2

2006

Other Studies

6 other study(ies) available for isoxazoles and thromboxane a2

ArticleYear
Supercooperativity in platelet aggregation: substituted pyridyl isoxazoles, a new class of supercooperative platelet aggregation inhibitors.
    FEBS letters, 1994, Sep-05, Volume: 351, Issue:2

    Topics: Allosteric Regulation; Arachidonic Acid; Bicyclic Monoterpenes; Dose-Response Relationship, Drug; Humans; Indomethacin; Isoxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Thromboxane A2

1994
Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:3

    Topics: Cell Differentiation; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Induction; Fetal Blood; Hematopoietic Stem Cells; Humans; Infant, Newborn; Isoenzymes; Isoxazoles; Megakaryocytes; Membrane Proteins; Nitrobenzenes; Platelet Count; Pluripotent Stem Cells; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Stem Cell Factor; Sulfonamides; Thrombopoiesis; Thrombopoietin; Thromboxane A2

2004
Coxibs and cardiovascular disease.
    The New England journal of medicine, 2004, Oct-21, Volume: 351, Issue:17

    Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Approval; Drug Industry; Epoprostenol; Gastrointestinal Diseases; Humans; Isoenzymes; Isoxazoles; Lactones; Membrane Proteins; Naproxen; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Risk; Sulfonamides; Sulfones; Thromboxane A2; United States; United States Food and Drug Administration

2004
Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells.
    Clinical immunology (Orlando, Fla.), 2006, Volume: 120, Issue:1

    Topics: B-Lymphocytes; Cell Growth Processes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprost; Dinoprostone; Enzyme Activation; Humans; Immunoglobulin Heavy Chains; Immunohistochemistry; Indomethacin; Isoxazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Nitrobenzenes; Pyrazoles; Sulfonamides; Sulfones; Thromboxane A2

2006
Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide.
    American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:4

    Topics: Animals; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Fatty Acids, Unsaturated; Feedback, Physiological; Hydrazines; Isoxazoles; Kidney Glomerulus; Kidney Tubules; Male; Membrane Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction

2009
Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
    Journal of medicinal chemistry, 2013, Jun-13, Volume: 56, Issue:11

    Topics: Animals; Blood Platelets; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epoprostenol; Female; Fibrinolytic Agents; Furans; Humans; Isoxazoles; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Rich Plasma; Structure-Activity Relationship; Thromboxane A2

2013
chemdatabank.com